Identification of a Novel Mutation in FOXL2 Gene That Leads to Blepharophimosis Ptosis Epicanthus Inversus and Telecanthus Syndrome in a Tunisian Consanguineous Family

Ibtissem Chouchene (1, 2) , Kaouthar Derouiche (1) , Ahlem Amouri (2) , Afif Chaabouni (1) , Lamia Cherif (2) , Leila Largueche (1) , Sonia Abdelhak (2) , Leila El Matri (1)

1 Oculogenetics Research Unit
2 Institut Pasteur de Tunis

Mutations in FOXL2 gene are responsible for blepharophimosis ptosis epicanthus inversus and telecanthus syndrome (BPES). The BPES syndrome is a rare autosomal dominant genetic disease characterized by eyelid malformations associated with premature ovarian failure (BPES type I) or not (BPES type II). The human FOXL2 protein (376 aa) contains a 100 amino-acid DNA-binding forkhead domain (residues 52-152) and a polyalanine tract (residues 221-234). In the present study, we report the molecular investigation of four affected members with BPES syndrome in a Tunisian consanguineous family. To identify the causative mutation, we performed a direct sequencing of the FOXL2 gene. The sequence analysis of the coding exon revealed a novel frameshift mutation g.1113 dup C, c.876 dup C, p.P292 Fs. The mutation is located downstream of the polyalanine tract and causes the protein extension to 532 aa. This study reports for the first time a novel frameshift mutation in two-generation consanguineous Tunisian family with BPES. Our results expand the spectrum of FOXL2 mutations.

Domains: Life Sciences [q-bio]

Ibtissem Chouchene, Kaouthar Derouiche, Ahlem Amouri, Afif Chaabouni, Lamia Cherif, et al.. Identification of a Novel Mutation in FOXL2 Gene That Leads to Blepharophimosis Ptosis Epicanthus Inversus and Telecanthus Syndrome in a Tunisian Consanguineous Family. Genetic Testing and Molecular Biomarkers, 2010, 14 (1), pp.145-148. ⟨10.1089/gtmb.2009.0091⟩. ⟨pasteur-01375297⟩